Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: AIDS Behav. 2018 Feb;22(2):412–420. doi: 10.1007/s10461-017-1847-x

Table II.

Trajectory Estimation and Group Membership among a sample of YGBMSM (N=94) participating in a 12-week rectal placebo gel trial

Model 1 Model 2
Single Trajectory Analysis Trajectory 1 (High & Varying
Use)
Trajectory 2 (Low &
Consistent Use)

b(SE) t p b(SE) t p b(SE) t p
Intercept .50(.07) 7.01 .0001 1.12(.09) 12.40 .0001 −.36(.14) −2.41 .02
Linear −.27(.07) −4.09 .0001 −.40(.08) −5.02 .0001 .10(.13) .73 .47
Quadratic .05(.01) 3.61 .001 .09(.02) 5.05 .0001 −.05(.03) −1.72 .09
Cubic −.003(.001) −3.57 .001 −.006(.001) −5.12 .0001 .004(.002) 1.90 .05
Probability of Membership
N=94 (100%) N=38 (40.3%) N=56 (59.7%)
Model Fit Statistics
BIC −1833.45 (N=94) −1595.42 (N=94)
AIC −1828.37 −1583.98

Notes. BIC = Bayesian Information Criterion; AIC = Akaike Information Criterion